Emerging within the UK, retatrutide, a novel peptide , is sparking considerable buzz within the scientific community regarding its promise for weight control . This dual GIP and GLP-1 target agonist looks to provide a considerable improvement over current therapies, showing promising results in early clinical trials . Researchers suggest its unique